# Amgen Inc: Form 8-K, filed Sep 1, 2023

- Company: [Amgen Inc](/companies/amgn.md) (CIK 318154)
- Form: 8-K
- Filed: 2023-09-01
- Accepted by EDGAR: Sep 1, 2023, 09:25 ET
- Period: 2023-09-01
- Accession: 0001193125-23-227040
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/318154/000119312523227040/d525571d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/318154/000119312523227040/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/318154/000119312523227040/d525571d8k.htm

Filed Sep 1, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-227040. Last ingested by Listed: Nov 10, 2026, 06:19 ET. No prices; not investment advice.